Recent Advances in Angiogenesis and ... - Bentham Science

Recent Advances in Angiogenesis and ... - Bentham Science Recent Advances in Angiogenesis and ... - Bentham Science

benthamscience.com
from benthamscience.com More from this publisher
01.07.2013 Views

32 Recent Advances in Angiogenesis and Antiangiogenesis, 2009 Crivellato and Ribatti therapy is a novel and effective approach for inflammatory bowel disease treatment. The VEGF family of growth factors control pathological angiogenesis and increased vascular permeability in important eye diseases such as diabetic retinopathy and age-related macular degeneration. Recent findings suggest a role of VEGFR-1 as a functional receptor for placenta growth factor (PlGF) and VEGF-A in pericytes and vascular smooth muscle cells in vivo rather than in endothelial cells [10]. In addition, VEGFs secreted by epithelia, including the retinal pigment epithelium, are likely to mediate paracrine vascular survival signals for adjacent endothelia. In the choroid, derailment of this paracrine relation and overexpression of VEGF-A by the retinal pigment epithelium may explain the pathogenesis of subretinal neovascularisation in age-related macular degeneration. On the other hand, this paracrine relation and other physiological functions of VEGFs may be endangered by therapeutic VEGF inhibition, as is currently used in several clinical trials in diabetic retinopathy and age-related macular degeneration. In addition to this, the VEGF family of growth factors appears to stimulate neuroprotection after stroke. Recent findings from experiments performed on animals with experimentally evoked focal cerebral ischemia suggest that the neuroprotective activity of VEGF runs in parallel with its ability to promote neurogenesis and angiogenesis and that these effects may operate independently through multiple mechanisms [11]. The above-mentioned three major features characterizing the neurobiological activity of VEGF, i.e. neuroprotection, neurogenesis, and angiogenesis, together with their possible functional link(s), provide the rationale for considering VEGFbased therapy as a promising future avenue for a more effective treatment of at least some neurodegenerative disorders and stroke. Moreover, the possibility of using neutralizing factors of VEGF or VEGF receptor antagonists may reveal a way of preventing many dangerous pathologies, including post-ischemic disturbances in cardiac and neurological disorders, or hypervascularization in avascular structures of the eye. 3. NEUTROPHILS Neutrophils, or polymorphonuclear granulocytes, are blood cell leukocytes which play a basic role in host defence and inflammation. During the acute inflammatory response, neutrophils extravasate from the circulation into the tissue, where they exert their defence functions. Increasing evidence supports the concept that these immune cells also contribute to inflammation-mediated angiogenesis in different flogistic conditions. Neutrophils indeed are a source of soluble mediators which, besides proinflammatory activity, exert important angiogenic functions. VEGF, interleukin (IL)-8, tumor necrosis factor (TNF)-, hepatocyte growth factor (HGF) and matrix metalloproteinases (MMPs) are the most important activators of angiogenesis produced by these cells [12- 14]. In this perspective, microarray technique has recently revealed about thirty angiogenesis-relevant genes in human polymorphonuclear granulocytes [15]. Interestingly, neutrophil-derived VEGF can stimulate neutrophil migration [16]. Thus neutrophil contribution to both normal and pathological angiogenesis may be sustained by an autocrine amplification mechanism that allows persistent VEGF release to occur at sites of neutrophil accumulation. Production and release of VEGF from neutrophils has been shown to depend from the granulocyte-colony stimulating factor (G-CSF) [17]. Evidence for the possible role of polymorphonuclear granulocytes in inflammation-mediated angiogenesis and tissue remodeling was initially provided by the finding that CXC receptor 2 (CXCR2)-deficient mice, which lacks neutrophil infiltration in thioglycollate-induced peritonitis [18], showed delayed angiogenesis and impaired cutaneous wound healing [19]. More recently, human polymorphonuclear granulocytes have demonstrated the ability to directly induce the sprouting of capillary-like structures in in vitro angiogenesis assay. This angiogenic capacity appears to be mediated by secretion of both preformed VEGF from cell stores and de novo synthesized IL-8 [15]. Angiogenesis is a hallmark of the synovium in chronic septic arthritis. Analysis of the synovium in patients with chronic pyogenic arthritis identified dramatic neovascularization and cell proliferation, accompanied by persistent bacterial colonization and heterogeneous inflammatory infiltrates rich in CD15+ neutrophils, as histopathologic hallmarks [20]. By using a modified angiogenic model, allowing for a direct analysis of exogenously added cells and their products in collagen onplants grafted on the chorioallantoic membrane of the chicken embryo, it has recently been demonstrated that intact human neutrophils and their granule contents are highly angiogenic [21]. Furthermore, purified neutrophil MMP-9, isolated from the released granules as a zymogen (proMMP-9), constitutes a distinctly potent proangiogenic moiety inducing angiogenesis at subnanogram levels. The angiogenic response induced by neutrophil proMMP-9 requires activation of the tissue inhibitor of metalloproteinases (TIMP)-free zymogen and the catalytic activity of the activated enzyme. Neutrophils not only activate but also modulate the angiogenic process. Neutrophil elastase, a serine protease released from the azurophil granules of activated neutrophil, proteolytically cleaves angiogenic growth factors such as basic-fibroblast growth factor (FGF)-2 and VEGF [22]. Neutrophil elastase degrades FGF-2 and VEGF in a time- and concentrationdependent manner, and these degradations are suppressed by sivelestat, a synthetic inhibitor of neutrophil elastase. The FGF-2- or VEGF-mediated proliferative activity of human umbilical vein

40 Recent Advances in Angiogenesis and Antiangiogenesis, 2009, 40-53 Thymus and Angiogenesis Marius Raica and Anca Maria Cimpean Domenico Ribatti (Ed.) All rights reserved - © 2009 Bentham Science Publishers Ltd. CHAPTER 5 Department of Histology and Molecular Pathology, “Victor Babes” University of Medicine and Pharmacy, 2 Eftimie Murgu Square, Tmisoara, 300041, Romania Address correspondence to: Dr. Marius Raica, Department of Histology and Molecular Pathology, “Victor Babes” University of Medicine and Pharmacy, 2 Eftimie Murgu Square, Tmisoara, 300041, Romania; Tel: 004- 0256204476; E-mail: raica@umft.ro 1. INTRODUCTION Abstract: Thymus plays a key role in the development of the immune system of the organism and vasculature seems to be involved in some steps of its development. Few data are available about vasculogenesis/angiogenesis in the thymus in normal and pathological conditions, despite the architecture of the vascular tree being relatively well known. There are some particular models of expression of endothelial cell (EC) markers in the thymus. In normal conditions, CD31 and CD105 are less expressed, opposite to CD34 and factor VIII that stain almost all vessels. The aspect is different in thymoma, where both CD31 and CD105 stain intratumoral blood vessels. Microvessel density significantly increases from normal thymus to thymic involution, myasthenia gravis and thymoma. In the tumor area, most of the vessels are immature or intermediate, and their number and type correlate with progression of thymoma. Proliferative ECs, defined by the co-expression of CD34 and Ki67, were found in high number mainly in high-grade advanced-stage thymoma. Progenitor ECs were not found in the prenatal and normal postnatal thymus, but isolated ECs that co-express AC133 and Tie2 were found in high grade thymoma. Besides ECs and perivascular cells, mast cells seem to be involved in thymus angiogenesis. A strong correlation was found between mast cell number and MVD. Few data are available about the expression of angiogenic factors and their receptors in the thymus. Vascular endothelial growth factor (VEGF) is expressed by epithelial cells of the normal thymus and overexpressed by tumor cells in thymoma B3 and thymic carcinoma. The expression of VEGF correlates with the presence of immature blood vessels and Masaoka clinical stage. VEGF receptors 1 and 2 are also expressed in normal and tumoral thymus. A divergent expression of VEGFR1 and 2 is found during thymoma progression. Other growth factors, like fibroblast growth factor and platelet derived growth factor and their receptors may contribute to angiogenesis in the thymus as they are expressed with different patterns in normal and pathological conditions. Lymphatic vessels seem to be better developed than previously thought, and they were also found in the thymic medulla. On the other hand, D2-40/podoplanin stains a subset of stromal epithelial cells and the corresponding thymoma. Thymus is not only a site for angiogenesis, but also a source for angiogenic factors. From these, it was shown that thymosins are involved not only in thymus but also in systemic angiogenesis. The thymus is a unique organ in the human body that initiates and maintains the normal functioning immune system. Since its development from the endoderm of the third pharyngeal pouch [1] till the late postnatal life, the thymus suffers some significant changes that are globally referred to as physiological involution or atrophy. These changes are more evident after puberty, and after 20-25 years, the general microscopic aspect maybe described as atrophy. An initial depletion in lymphocytes and changes in the arrangement of epithelial cells characterize this process [2]. The general microscopic appearance of the postnatal thymus is characterized by the parenchyma with cortex, containing densely packed lymphocytes, and medulla with less lymphocytes and more heterogeneous cell population (Fig. 1). In the medulla reside the typical structures of the thymus known as Hassall’s bodies that consist of epithelial cells and scattered S100 positive cells. Hassall’s corpuscles are not residual structures because it was demonstrated that epithelial cells secrete thymic stromal lymphopoietin that is crucial for B and T lymphocytes development in the medulla [3, 4]. Interestingly, the thymus medulla seems to arise as a series of clonal islets that aggregate as the thymus matures [5]. The close association of the adult medullary compartment with the vasculature could indicate that blood vessels may have a role in the initial organization of the mature medulla. Medullary epithelium was associated with intermediate size blood vessels, but not with capillaries or large vessels [6]. This effect might be

40 <strong>Recent</strong> <strong>Advances</strong> <strong>in</strong> <strong>Angiogenesis</strong> <strong>and</strong> Antiangiogenesis, 2009, 40-53<br />

Thymus <strong>and</strong> <strong>Angiogenesis</strong><br />

Marius Raica <strong>and</strong> Anca Maria Cimpean<br />

Domenico Ribatti (Ed.)<br />

All rights reserved - © 2009 <strong>Bentham</strong> <strong>Science</strong> Publishers Ltd.<br />

CHAPTER 5<br />

Department of Histology <strong>and</strong> Molecular Pathology, “Victor Babes” University of Medic<strong>in</strong>e <strong>and</strong> Pharmacy, 2<br />

Eftimie Murgu Square, Tmisoara, 300041, Romania<br />

Address correspondence to: Dr. Marius Raica, Department of Histology <strong>and</strong> Molecular Pathology, “Victor<br />

Babes” University of Medic<strong>in</strong>e <strong>and</strong> Pharmacy, 2 Eftimie Murgu Square, Tmisoara, 300041, Romania; Tel: 004-<br />

0256204476; E-mail: raica@umft.ro<br />

1. INTRODUCTION<br />

Abstract: Thymus plays a key role <strong>in</strong> the development of the immune system of the organism<br />

<strong>and</strong> vasculature seems to be <strong>in</strong>volved <strong>in</strong> some steps of its development. Few data are available<br />

about vasculogenesis/angiogenesis <strong>in</strong> the thymus <strong>in</strong> normal <strong>and</strong> pathological conditions, despite<br />

the architecture of the vascular tree be<strong>in</strong>g relatively well known. There are some particular<br />

models of expression of endothelial cell (EC) markers <strong>in</strong> the thymus. In normal conditions,<br />

CD31 <strong>and</strong> CD105 are less expressed, opposite to CD34 <strong>and</strong> factor VIII that sta<strong>in</strong> almost all<br />

vessels. The aspect is different <strong>in</strong> thymoma, where both CD31 <strong>and</strong> CD105 sta<strong>in</strong> <strong>in</strong>tratumoral<br />

blood vessels. Microvessel density significantly <strong>in</strong>creases from normal thymus to thymic<br />

<strong>in</strong>volution, myasthenia gravis <strong>and</strong> thymoma. In the tumor area, most of the vessels are<br />

immature or <strong>in</strong>termediate, <strong>and</strong> their number <strong>and</strong> type correlate with progression of thymoma.<br />

Proliferative ECs, def<strong>in</strong>ed by the co-expression of CD34 <strong>and</strong> Ki67, were found <strong>in</strong> high number<br />

ma<strong>in</strong>ly <strong>in</strong> high-grade advanced-stage thymoma. Progenitor ECs were not found <strong>in</strong> the prenatal<br />

<strong>and</strong> normal postnatal thymus, but isolated ECs that co-express AC133 <strong>and</strong> Tie2 were found <strong>in</strong><br />

high grade thymoma. Besides ECs <strong>and</strong> perivascular cells, mast cells seem to be <strong>in</strong>volved <strong>in</strong><br />

thymus angiogenesis. A strong correlation was found between mast cell number <strong>and</strong> MVD.<br />

Few data are available about the expression of angiogenic factors <strong>and</strong> their receptors <strong>in</strong> the<br />

thymus. Vascular endothelial growth factor (VEGF) is expressed by epithelial cells of the<br />

normal thymus <strong>and</strong> overexpressed by tumor cells <strong>in</strong> thymoma B3 <strong>and</strong> thymic carc<strong>in</strong>oma. The<br />

expression of VEGF correlates with the presence of immature blood vessels <strong>and</strong> Masaoka<br />

cl<strong>in</strong>ical stage. VEGF receptors 1 <strong>and</strong> 2 are also expressed <strong>in</strong> normal <strong>and</strong> tumoral thymus. A<br />

divergent expression of VEGFR1 <strong>and</strong> 2 is found dur<strong>in</strong>g thymoma progression. Other growth<br />

factors, like fibroblast growth factor <strong>and</strong> platelet derived growth factor <strong>and</strong> their receptors may<br />

contribute to angiogenesis <strong>in</strong> the thymus as they are expressed with different patterns <strong>in</strong> normal<br />

<strong>and</strong> pathological conditions. Lymphatic vessels seem to be better developed than previously<br />

thought, <strong>and</strong> they were also found <strong>in</strong> the thymic medulla. On the other h<strong>and</strong>, D2-40/podoplan<strong>in</strong><br />

sta<strong>in</strong>s a subset of stromal epithelial cells <strong>and</strong> the correspond<strong>in</strong>g thymoma. Thymus is not only a<br />

site for angiogenesis, but also a source for angiogenic factors. From these, it was shown that<br />

thymos<strong>in</strong>s are <strong>in</strong>volved not only <strong>in</strong> thymus but also <strong>in</strong> systemic angiogenesis.<br />

The thymus is a unique organ <strong>in</strong> the human body that<br />

<strong>in</strong>itiates <strong>and</strong> ma<strong>in</strong>ta<strong>in</strong>s the normal function<strong>in</strong>g immune<br />

system. S<strong>in</strong>ce its development from the endoderm of<br />

the third pharyngeal pouch [1] till the late postnatal<br />

life, the thymus suffers some significant changes that<br />

are globally referred to as physiological <strong>in</strong>volution or<br />

atrophy. These changes are more evident after puberty,<br />

<strong>and</strong> after 20-25 years, the general microscopic aspect<br />

maybe described as atrophy. An <strong>in</strong>itial depletion <strong>in</strong><br />

lymphocytes <strong>and</strong> changes <strong>in</strong> the arrangement of<br />

epithelial cells characterize this process [2].<br />

The general microscopic appearance of the postnatal<br />

thymus is characterized by the parenchyma with<br />

cortex, conta<strong>in</strong><strong>in</strong>g densely packed lymphocytes, <strong>and</strong><br />

medulla with less lymphocytes <strong>and</strong> more<br />

heterogeneous cell population (Fig. 1). In the medulla<br />

reside the typical structures of the thymus known as<br />

Hassall’s bodies that consist of epithelial cells <strong>and</strong><br />

scattered S100 positive cells. Hassall’s corpuscles are<br />

not residual structures because it was demonstrated<br />

that epithelial cells secrete thymic stromal<br />

lymphopoiet<strong>in</strong> that is crucial for B <strong>and</strong> T lymphocytes<br />

development <strong>in</strong> the medulla [3, 4]. Interest<strong>in</strong>gly, the<br />

thymus medulla seems to arise as a series of clonal<br />

islets that aggregate as the thymus matures [5]. The<br />

close association of the adult medullary compartment<br />

with the vasculature could <strong>in</strong>dicate that blood vessels<br />

may have a role <strong>in</strong> the <strong>in</strong>itial organization of the<br />

mature medulla. Medullary epithelium was associated<br />

with <strong>in</strong>termediate size blood vessels, but not with<br />

capillaries or large vessels [6]. This effect might be

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!